These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23889950)

  • 21. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
    Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
    Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
    Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
    Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidental primary breast cancer detected on PET-CT.
    Benveniste AP; Marom EM; Benveniste MF; Mawlawi O; Fox PS; Yang W
    Breast Cancer Res Treat; 2015 Jun; 151(2):261-8. PubMed ID: 25929765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP; David S; Alamgeer M; Ganju V
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer.
    Jo JE; Kim JY; Lee SH; Kim S; Kang T
    Acta Radiol; 2015 Dec; 56(12):1463-70. PubMed ID: 25406431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis.
    Pan L; Han Y; Sun X; Liu J; Gang H
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):1007-22. PubMed ID: 20091186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications.
    De Placido S; De Angelis C; Giuliano M; Pizzi C; Ruocco R; Perrone V; Bruzzese D; Tommasielli G; De Laurentiis M; Cammarota S; Arpino G; Arpino G
    Br J Cancer; 2017 Mar; 116(6):821-827. PubMed ID: 28170371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
    Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
    Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
    Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
    Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
    Srour MK; Lee M; Walcott-Sapp S; Luu M; Chung A; Giuliano AE; Amersi F
    Ann Surg Oncol; 2019 Oct; 26(10):3289-3294. PubMed ID: 31342365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pattern of Imaging after Lung Cancer Resection. 1992-2005.
    Sharma G; Nishi SP; Lin YL; Kuo YF; Goodwin JS; Riall TS
    Ann Am Thorac Soc; 2016 Sep; 13(9):1559-67. PubMed ID: 27243464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two cases of occult breast cancer in which PET-CT was helpful in identifying primary tumors.
    Takabatake D; Taira N; Aogi K; Ohsumi S; Takashima S; Inoue T; Nishimura R
    Breast Cancer; 2008; 15(2):181-4. PubMed ID: 18274836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical roles of breast 3T MRI, FDG PET/CT, and breast ultrasound for asymptomatic women with an abnormal screening mammogram.
    Chou CP; Peng NJ; Chang TH; Yang TL; Hu C; Lin HS; Huang JS; Pan HB
    J Chin Med Assoc; 2015 Dec; 78(12):719-25. PubMed ID: 26364959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI and PET/CT of patients with bone metastases from breast carcinoma.
    Grankvist J; Fisker R; Iyer V; Fründ ET; Simonsen C; Christensen T; Stenbygaard L; Ewertz M; Larsson EM
    Eur J Radiol; 2012 Jan; 81(1):e13-8. PubMed ID: 21227614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.
    Riegger C; Herrmann J; Nagarajah J; Hecktor J; Kuemmel S; Otterbach F; Hahn S; Bockisch A; Lauenstein T; Antoch G; Heusner TA
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):852-63. PubMed ID: 22392069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.
    Kim TH; Yoon JK; Kang DK; Lee SJ; Jung YS; Yim H; An YS
    Ann Surg Oncol; 2015 Nov; 22(12):3866-72. PubMed ID: 25805237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.
    Groheux D; Giacchetti S; Espié M; Vercellino L; Hamy AS; Delord M; Berenger N; Toubert ME; Misset JL; Hindié E
    J Nucl Med; 2011 Oct; 52(10):1526-34. PubMed ID: 21880576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
    Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
    Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.